Iris Löw-Friedrich
Chief Executive Officer bij ZOGENIX, INC.
Profiel
Dr. Iris Lw-Friedrich is Vice-Voorzitter-Raad van Toezicht bij Evotec SE, Chief Medical Officer & Executive Vice President bij UCB SA en Professor aan de Johann Wolfgang Goethe-Universitt Frankfurt am Main. Zij zetelt in de Raad van Bestuur van Fresenius SE & Co. KGaA en Evotec SE. Dr. Lw-Friedrich was voorheen werkzaam als Voorzitter bij Transcelerate Biopharma, Inc, als Lid-Raad van Toezicht bij Heidelberg Pharma AG, als Directeur-Research & Development bij UCB Pharma GmbH, als Vice-President-Global Projects bij BASF Pharma, als Vice-President-Global Projects bij BASF AG, als Vice-President-Clinical Development bij Hoechst AG, als Hoofd-Global Clinical Management & VP bij Aventis Pharma AG, en als Vice-President-Clinical Development bij Hoechst Marion Roussel, Inc. Zij behaalde haar doctoraat aan de Johann Wolfgang Goethe-Universitt Frankfurt am Main.
Actieve functies van Iris Löw-Friedrich
| Bedrijven | Functie | Begin |
|---|---|---|
| UCB | Chief Tech/Sci/R&D Officer | 01-03-2008 |
| EVOTEC SE | Chairman | 15-06-2021 |
| FRESENIUS SE & CO. KGAA | Director/Board Member | 13-05-2016 |
| ZOGENIX, INC. | Chief Executive Officer | - |
| Johann Wolfgang Goethe-Universität Frankfurt am Main | Corporate Officer/Principal | 01-01-2000 |
PhRMA Foundation
 PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services The PhRMA Foundation is an organization that provides awards and support to individuals pursuing higher education. The non-profit company is based in Washington. The organization's 2022 annual report highlights their activities and showcases their 2022 awardees. | Director/Board Member | 01-04-2019 |
Eerdere bekende functies van Iris Löw-Friedrich
| Bedrijven | Functie | Einde |
|---|---|---|
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Chairman | 01-09-2017 |
UCB Pharma GmbH
 UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany. | Chief Tech/Sci/R&D Officer | 01-01-2009 |
| BASF SE | Corporate Officer/Principal | 01-01-2001 |
| ░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Iris Löw-Friedrich
| Johann Wolfgang Goethe-Universität Frankfurt am Main | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 5 |
|---|---|
| FRESENIUS SE & CO. KGAA | Health Technology |
| BASF SE | Process Industries |
| UCB | Health Technology |
| EVOTEC SE | Health Technology |
| HEIDELBERG PHARMA AG | Health Technology |
| Bedrijven in privébezit | 8 |
|---|---|
Hoechst AG
 Hoechst AG Chemicals: Major DiversifiedProcess Industries Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany. | Process Industries |
UCB Pharma GmbH
UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany. | Health Technology |
Zogenix, Inc.
 Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. | Health Technology |
| Aventis Pharma AG | |
| Hoechst Marion Roussel, Inc. | |
| BASF Pharma | |
PhRMA Foundation
PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services The PhRMA Foundation is an organization that provides awards and support to individuals pursuing higher education. The non-profit company is based in Washington. The organization's 2022 annual report highlights their activities and showcases their 2022 awardees. | Commercial Services |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Health Technology |
